Rhythm Pharmaceuticals, Inc. (FRA:1RV)

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,387	3,323	2,458	1,535	441	1,074
Market Cap Growth	81.28%	35.21%	60.08%	248.05%	-58.94%	19.54%
Enterprise Value	6,253	3,281	2,188	1,212	155	912
Last Close Price	93.50	53.00	41.60	27.80	9.30	24.20
PS Ratio	42.98	26.44	35.09	69.42	159.06	-
PB Ratio	25.34	20.91	16.00	6.21	1.77	7.89
P/TBV Ratio	52.30	221.17	16.69	6.40	1.80	7.89
EV/Sales Ratio	42.03	26.10	31.24	54.79	55.81	-
Debt / Equity Ratio	0.38	0.69	0.63	0.29	0.01	0.02
Asset Turnover	0.40	0.36	0.22	0.07	0.01	-
Inventory Turnover	1.03	0.98	1.61	1.41	-	-
Quick Ratio	4.31	2.94	5.27	8.53	6.81	9.60
Current Ratio	4.75	3.24	5.58	8.90	7.10	10.10
Return on Equity (ROE)	-85.79%	-155.91%	-85.10%	-66.05%	-30.89%	-59.88%
Return on Assets (ROA)	-26.74%	-45.77%	-32.22%	-31.45%	-41.15%	-34.45%
Return on Capital (ROIC)	-34.49%	-59.75%	-37.22%	-35.62%	-46.59%	-37.59%
Return on Capital Employed (ROCE)	-46.30%	-95.90%	-66.40%	-52.30%	-59.40%	-80.80%
Earnings Yield	-2.64%	-7.58%	-6.80%	-11.04%	-13.88%	-10.20%
FCF Yield	-	-3.31%	-5.01%	-10.59%	-29.19%	-9.30%
Buyback Yield / Dilution	-5.39%	-5.76%	-10.65%	-5.08%	-12.40%	-21.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.